Van Hulzen Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400
| Closed | -$7.34K | – | 318 |
|
|
2024
Q4 | $7.34K | Sell |
400
-99,381
| -100% | -$1.82M | ﹤0.01% | 807 |
|
|
2024
Q3 | $1.54M | Buy |
99,781
+8,296
| +9% | +$128K | 0.11% | 134 |
|
|
2024
Q2 | $1.49M | Buy |
91,485
+14,231
| +18% | +$231K | 0.1% | 134 |
|
|
2024
Q1 | $1.43M | Sell |
77,254
-1,396
| -2% | -$25.8K | 0.09% | 139 |
|
|
2023
Q4 | $2.46M | Buy |
78,650
+25,580
| +48% | +$801K | 0.17% | 94 |
|
|
2023
Q3 | $1.11M | Buy |
53,070
+24,180
| +84% | +$504K | 0.09% | 144 |
|
|
2023
Q2 | $692K | Sell |
28,890
-760
| -3% | -$18.2K | 0.06% | 148 |
|
|
2023
Q1 | $558K | Buy |
+29,650
| New | +$558K | 0.05% | 167 |
|